While the animal study did not have a weight loss intervention, the observed positive association between obesity, leptin levels, and breast cancer recurrence provided a biological rationale for conducting weight loss interventions on breast cancer survivors with overweight or obesity. The gene discussed is LEP; the disease is obesity disorder.